Analgesics (Pharmacies) - Equatorial Guinea

  • Equatorial Guinea
  • Revenue in the Analgesics market is projected to reach US$3.85m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.85%, resulting in a market volume of US$3.69m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.19 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Equatorial Guinea is experiencing steady growth due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of this market. Customer preferences play a significant role in shaping the Analgesics (Pharmacies) market in Equatorial Guinea. Consumers in this country have shown a growing interest in self-medication and over-the-counter pain relief products. This preference for easily accessible medication has led to an increase in the demand for analgesics in pharmacies. Additionally, customers in Equatorial Guinea have shown a preference for trusted and well-known brands, which has further fueled the growth of the market. Trends in the market also contribute to the development of the Analgesics (Pharmacies) market in Equatorial Guinea. One notable trend is the increasing awareness and importance of healthcare and wellness among the population. This trend has led to a greater emphasis on preventive healthcare and the need for pain relief options. As a result, pharmacies are expanding their range of analgesic products to cater to this growing demand. Moreover, the market is witnessing a shift towards more natural and herbal analgesics, as consumers are becoming more conscious of the potential side effects of conventional medication. Local special circumstances in Equatorial Guinea also impact the Analgesics (Pharmacies) market. The country has a relatively small population, which means that the market size is limited. However, the government has been investing in healthcare infrastructure and promoting access to medication, which has created opportunities for growth in the analgesics market. Additionally, the presence of a large number of pharmacies in urban areas ensures easy availability of analgesics to the population. Underlying macroeconomic factors also contribute to the development of the Analgesics (Pharmacies) market in Equatorial Guinea. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income. This rise in income levels has led to an increase in healthcare expenditure, including the purchase of analgesics. Furthermore, the government's efforts to improve healthcare services and ensure affordable access to medication have also contributed to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Equatorial Guinea is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The growing interest in self-medication, the emphasis on healthcare and wellness, and the government's investments in healthcare infrastructure are all driving the growth of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)